Research
Click on a title below to read or download the full article in pdf format.
Published Journal Articles
Is there Anyone who Should Not Participate in an Immune12 Trial?
Pregnant and nursing women should not take Immune12 due to a lack of clinical studies in that population. Anyone taking an anti-coagulant should be under a
History of Pacific Marine Biotech, LLC
Pacific Marine Biotech, LLC (PMB) was formed in 2022, born out of a vision to explore the vast potential of marine biology in advancing human health. Our journey began over 40 years ago in Australia, a region known for its rich marine biodiversity. Below is a chronology of events leading up to the formation of PMB.
Availability of Immune12
Immune-12 is currently not available to the general public except via participation in one of our trials.
Clinical Trials
PMB’s Primary Area of Focus
PMB’s focus is on launching clinical trials for GBM and DIPG using its product, Immune12, a complex biologic compound derived from marine organisms.
GBM and DIPG are orphan diseases with no cure. Current treatments may extend life by several months but are not curative.
Upon diagnosis, patients face a grim reality with little to no hope for recovery. While existing standard-of-care treatments like radiation and chemotherapy may extend life by a few months, they fall significantly short of providing a cure. Moreover, the side effects associated with these treatments can be severe and debilitating, further compromising the quality of life for patients.
Media & Press Inquiries
Pacific Marine Biotech, LLC8 Church Street, First FloorTorrington, Connecticut, 06790 USA Phone : (959) 901-4041Email : info@pacificmarinebiotech.comWeb site : www.pacificmarinebiotech.com Media and Press InquiriesJames SokEmail